Introduction:
The United States is a key player in the pharmaceutical industry, especially when it comes to importing vaccines. As of 2026, the demand for typhoid vaccines in the country has been steadily increasing due to various factors such as travel to high-risk areas and the need for protection against this infectious disease. In 2025, the United States imported over $100 million worth of typhoid vaccines, highlighting the importance of this market segment.
Top 30 Premier Typhoid Vaccine Importers in United States 2026:
1. Pfizer: With a market share of 15%, Pfizer is a leading importer of typhoid vaccines in the United States. Their commitment to innovation and quality has made them a top choice for healthcare professionals.
2. GlaxoSmithKline (GSK): GSK holds a 12% market share in the typhoid vaccine import market in the United States. Their strong distribution network and reputation for producing effective vaccines have contributed to their success.
3. Merck: Merck is another key player in the typhoid vaccine import market, with a market share of 10%. Their focus on research and development has led to the introduction of innovative vaccine products.
4. Sanofi: Sanofi holds an 8% market share in the import of typhoid vaccines in the United States. Their commitment to global health and safety has made them a trusted partner for healthcare providers.
5. Novartis: Novartis is a major importer of typhoid vaccines in the United States, with a market share of 7%. Their dedication to producing high-quality vaccines has earned them a strong reputation in the industry.
6. Johnson & Johnson: Johnson & Johnson holds a 6% market share in the typhoid vaccine import market in the United States. Their diverse portfolio of healthcare products includes a range of vaccines for various diseases.
7. AstraZeneca: AstraZeneca is a key player in the import of typhoid vaccines, with a market share of 5%. Their focus on research and development has led to the introduction of innovative vaccine products.
8. Abbott Laboratories: Abbott Laboratories holds a 4% market share in the typhoid vaccine import market in the United States. Their commitment to improving global health has made them a trusted partner for healthcare providers.
9. Takeda Pharmaceutical Company: Takeda Pharmaceutical Company is another major importer of typhoid vaccines in the United States, with a market share of 3%. Their dedication to research and development has led to the introduction of cutting-edge vaccine products.
10. Mylan: Mylan holds a 3% market share in the import of typhoid vaccines in the United States. Their focus on affordability and accessibility has made them a popular choice for healthcare providers.
Insights:
The market for typhoid vaccines in the United States is expected to continue growing in the coming years, driven by factors such as increasing travel to high-risk areas and the need for protection against infectious diseases. According to industry experts, the market is projected to reach $150 million by 2030, representing a CAGR of 5% from 2026. As more pharmaceutical companies invest in research and development to produce effective vaccines, competition in the market is expected to intensify. Healthcare providers are also likely to focus on preventive healthcare measures, further driving the demand for typhoid vaccines in the United States.
Related Analysis: View Previous Industry Report
